TREATMENT OF TYPE 1 DIABETES WITH PDE5 INHIBITORS - Patent 1605925

(19)

(11)

EP 1 605 925 A1

(12)

(43)	Date of publication:
	21.12.2005 Bulletin 2005/51

(21)	Application number: 04717183.0

(22)	Date of filing: 04.03.2004

(51)	International Patent Classification (IPC)⁷: A61K 31/00, A61K 31/519, A61K 31/53, A61P 3/10, A61K 38/28, A61K 31/4535, A61K 31/40, A61K 31/506, A61K 31/405, A61K 31/366, A61K 31/22, A61K 31/4709

(86)	International application number:
	PCT/IB2004/000696

(87)	International publication number:
	WO 2004/082667 (30.09.2004 Gazette 2004/40)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
	Designated Extension States:
	AL LT LV MK

(30)

Priority:

17.03.2003 US 455277 P

(71)	Applicant: Pfizer Products Inc.
	Groton,Connecticut 06340 (US)

(72)	Inventors:
	BURGESS, Gillian, Munro SandwichKent CT13 9NJ (GB) GIBBS, Earl, Michael Groton, CT 06340 (US) WAYMAN, Christopher, Peter SandwichKent CT13 9NJ (GB)

(74)	Representative: Motion, Keith Robert et al
	Pfizer Limited, European Pharma Patent Department, Ramsgate Road Sandwich,Kent CT13 9NJ Sandwich,Kent CT13 9NJ (GB)

(54)	TREATMENT OF TYPE 1 DIABETES WITH PDE5 INHIBITORS